Identification of a potential lead structure for designing new antimicrobials to treat infections caused by Staphylococcus epidermidis- resistant strains

Current Microbiology

Volumn 57, Issue 5, 2008, Pages 463-468

  Pinheiro, Luiz C S ^a   Abreu, Paula A ^a   Afonso, Ilidio F ^b   Leal, Bruno ^a   Corrêa, Luiz C D ^a   Borges, Júlio C ^a   Marques, Isakelly P ^a   Lourenço, André L ^a   Sathler, Plinio ^a   Dos Santos, Andre L ^a   Medeiros, Cid A ^a   Cabral, Lúcio M ^b   Júnior, Maurício L O ^a   Romeiro, Gilberto A ^a   Ferreira, Vitor F ^a   Rodrigues, Carlos R ^b   Castro, Helena C ^a   Bernardino, Alice M R ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 (PHENYLAMINO)THIENO[2,3 B]PYRIDINE; 4 (PHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBONITRILE; 4 CHLOROTHIENO[2,3 B]PYRIDINE; [5 (1H TETRAZOL 5 YL) 4 (3' METHYLPHENYLAMINO)THIENO[2,3B]PYRIDINE]; ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; OXACILLIN; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; DRUG ABSORPTION; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR MODEL; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PYRIDINES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS EPIDERMIDIS;

EID: 53849138676     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-008-9234-5     Document Type: Article

References (19)

1. JY Ang E Ezike BI Asmar 2004 Antibacterial resistance Symp Ser Soc Appl Microbiol 3 229 239
2. AMR Bernardino AR Azevedo LCS Pinheiro JC Borges VL Carvalho MD Miranda MDF Meneses M Nascimento D Ferreira MA Rebello VAGG Silva ICPP Frugulhetti 2007 Synthesis and antiviral activity of new 4-(phenylamino)/4-[(methylpyridin-2-yl) amino]-1-phenyl-1H-pyrazolo[3, 4-b]pyridine-4-carboxylic acids derivatives Med Chem Res 16 352 369
3. AMR Bernardino HC Castro ICPP Frugulhetti NIV Loureiro R Alexandre AR Azevedo LCS Pinheiro TML Souza V Giongo F Passamani UO Magalhães MG Albuquerque LM Cabral CR Rodrigues 2008 SAR of a series of anti-HSV-1acridone derivatives, and a rational acridone-based design of a new anti-HSV-1 3H-benzo[b]pyrazolo[3, 4-h]-1, 6-naphthyridine series Bioorg Med Chem 16 313 321
4. AMR Bernardino LCS Pinheiro CR Rodrigues NI Loureiro HC Castro A Lanfredi-Rangel J Sabatini-Lopes JC Borges JM Carvalho GA Romeiro VF Ferreira ICPP Frugulhetti MA Vannier-Santos 2006 Design, synthesis, SAR, and biological evaluation of new 4-(phenylamino)thieno[2, 3-b]pyridine derivatives Bioorg Med Chem 14 5765
5. A Burger 1991 Isosterism and bioisosterism in drug design Prog Drug Res 37 287 371
6. BA Cunha 2007 Oral versus IV treatment for catheter-related bloodstream infections Emerg Infect Dis 13 1800 1801
7. MM El-Abadelah MZ Nazer SF Okasha M Calas J Bompartc P Miond 1998 Thienopyridinone antibacterials: synthesis and antibacterial activity of some 7-aryl-2-chloro-4, 7-dihydro-4-oxothieno[2, 3-b]pyridine-5-carboxylic acids Eur J Med Chem 33 33 42
8. Hansch C, Leo L (1995) Exploring QSAR. Fundamentals and applications in chemistry and biology. American Chemical Society, Washington, DC
9. RJ Herr 2002 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods Bioorg Med Chem 10 3379 3393
10. RN Jones 2001 Resistance patterns among nosocomial pathogens: trends over the past few years Chest 119 397 404
11. CA Lipinski 2004 Lead and drug-like compounds: the rule-of-five revolution Drug Discov Today Technol 1 337 341
12. BB Lohray VB Lohray BK Srivastava PB Kapadnis P Pandya 2004 Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent Bioorg Med Chem 12 4557 4564
13. H Mello A Echevarria AMR Bernardino M Canto-Cavalheiro LL Leon 2004 Antileishmanial pyrazolopyridine derivatives: synthesis and structure-activity relationship analysis J Med Chem 47 5427 5432
14. KA Melstrom Jr JW Smith RL Gamelli R Shankar 2006 New perspectives for a new century: implications of pathogen responses for the future of antimicrobial therapy J Burn Care Res 27 251 264
15. CGT Oliveira FF Miranda VF Ferreira CC Freitas JM Carballido LCD Corrêa 2001 Synthesis and antimicrobial evaluation of 3-hydrazino- naphthoquinones as analogs of lapachol J Braz Chem Soc 12 339 345
16. M Otto 2008 Staphylococcal biofilms Curr Top Microbiol Immunol 322 207 228
17. LCS Pinheiro AR Azevedo ICPP Frugulhetti JL Carneiro M de TML Souza VF Ferreira AMR Bernardino 2004 Synthesis and antiviral activity of new 4-(phenylamino)thieno[2, 3-b]pyridine derivatives Heterocycl Commun 10 407 410
18. P Ramritu K Halton P Collignon D Cook D Fraenkel D Battistutta M Whitby N Graves 2008 A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care unit Am J Infect Control 36 104 117
19. H Singh AS Chawla VK Kapoor D Paul RK Malhotra 1980 Medicinal chemistry of tetrazoles Prog Med Chem 17 151 183